John Alexander
About John Alexander
John Alexander serves as the Vice President and Head of Intellectual Property at Nimbus Therapeutics, bringing extensive experience in patent prosecution and a strong background in life sciences and medical devices.
Current Role at Nimbus Therapeutics
John Alexander serves as the Vice President and Head of Intellectual Property at Nimbus Therapeutics, a position he has held since 2022. In this role, he oversees the company's intellectual property strategy and management, contributing to the protection and commercialization of innovative therapies. Nimbus Therapeutics is known for its focus on drug discovery and development, particularly in the field of life sciences.
Previous Experience at Amgen
Prior to his current role, John Alexander worked at Amgen as Senior Intellectual Property Counsel from 2017 to 2022. During his five years in Cambridge, Massachusetts, he was responsible for managing intellectual property matters and supporting the company's strategic initiatives in the biotechnology sector.
Background in Patent Law
John Alexander has extensive experience in patent prosecution within the pharmaceuticals industry. He worked at Novartis Institutes for BioMedical Research (NIBR) for a total of 11 years, first as a Patent Attorney from 2006 to 2009 and later as Senior Patent Attorney from 2009 to 2017. His roles involved navigating complex patent issues and supporting the development of pharmaceutical innovations.
Education and Expertise
John Alexander holds a Bachelor of Arts in Chemistry from Dartmouth College, where he studied from 1991 to 1995. He also earned a Ph.D. in Chemistry from the Massachusetts Institute of Technology, completing his studies from 1995 to 1999. Additionally, he obtained a Juris Doctor (J.D.) from Suffolk University Law School, graduating in 2004. His educational background provides a strong foundation in both scientific research and legal expertise, particularly in life sciences and medical devices.
Research and Development Background
John Alexander has a background in research and development, particularly in chemistry. He served as a Post Doctoral Fellow at Cornell University from 1999 to 2000, where he furthered his research capabilities. This experience complements his legal career, allowing him to bridge the gap between scientific innovation and intellectual property law.